Clinical Trial Update: A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Avastin (bevacizumab) in combination with Xeloda (capecitabine) for advanced or metastatic hepatocellular carcinoma; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-06